Physician profile
Jonathan Fabriziani
NPI 1194343509
$5,763.43
in general payments reported to CMS, 2019-2025
18 companies · $4,120 in 2025
The $4,120 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.45 · 2021: $82.17 · 2022: $417 · 2023: $408 · 2024: $720 · 2025: $4,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,748 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,748.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $2,500.00 | 2025 | Optilight |
| Bausch & Lomb Americas INC. | $972.44 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Coopervision INC. | $826.27 | 2021-2025 | Misight Contact Lens, Myday Contact Lens |
| Abbvie INC. | $370.99 | 2022-2025 | |
| Alcon Vision LLC | $180.45 | 2023-2025 | Precision 1, Precision7, Rocklatan |
| Dompe US, INC. | $168.68 | 2022-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $142.42 | 2023-2025 | Acuvue |
| Allergan, INC. | $120.00 | 2022 | |
| Mallinckrodt Hospital Products INC. | $104.49 | 2024-2025 | Acthar |
| Astellas Pharma US INC | $99.64 | 2024-2025 | Izervay |
| Biotissue Holdings INC. | $59.47 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $50.77 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $48.36 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.88 | 2021 | |
| Maculogix, INC. | $27.16 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $20.41 | 2025 | Purified Cortrophin Gel |
| Thea Pharma INC. | $19.15 | 2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $18.85 | 2025 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Fabriziani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.